June 25, 2024

Nutraceutical Ingredients Market Size to Surpass US$ 330 Billion by 2030

The global nutraceutical ingredients market size reached  USD 189.54 billion in 2022 and is expected to grow to around USD 330 billion by 2030, at a CAGR of 7.18% during the forecast period from 2022 to 2030.

Nutraceutical Ingredients Market Size 2021 to 2030

Key Takeaways

  • North America led the global market with the largest market share in 2021.
  • By Type, the probiotic segment has held the largest revenue share in 2021.
  • By Application, the food segment has held the highest market share in 2022.
  • By Application, the dietary segment is anticipated to grow at the fastest CAGR over the projected period.

Due to growing consumer demand for nutraceutical products such as probiotics, prebiotics, and vitamins, the global market for nutraceutical ingredients is expected to rise at a significant pace. The ingredients of nutraceuticals are derived from animals, plants, microbials and help provide food products with additional nutritional value. They are gluten-free and do not contain artificial colors and flavors, which makes them a healthy alternative to conventional products.

Get the Sample Pages of the Report for More Understanding@ https://www.precedenceresearch.com/sample/1162

Nutraceutical Ingredients Market Scope 

Report Highlights Details
Market Size in 2023 USD 203.14 Billion
Market Size by 2030 USD 330 Billion
Growth Rate from 2022 to 2030 CAGR of 7.18%
Largest Market North America
Fastest Growing Market Asia Pacific
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Type, Application, Health Benefits, Form, Region
Companies Mentioned GlaxoSmithKline, Kraft Heinz Company,  Abbott, Kellogg’s, Danone, Cargill Inc., Amway,Nestle, Archer Daniels Midland, DSM, BASF, PepsiCo, General Mills, Aker Biomarine, Procter & Gamble, Johnson & Johnson

Read More: Electric Vehicle Charging Station Market Size to Surpass Around USD 39.2 Bn by 2032

Growth Factors

Nutraceutical is a material that adds nutritional value to the diet, known as a meal or part of a meal. It is also classified as a functional food that contains standardised and pharmaceutical-grade nutrients. The item functions by diet & works to prevent diseases as a source of nutritional supplement to the body. Rising chronic disease penetration will fuel the demand for nutraceutical ingredients. Key properties can help product penetration, including prevention of heart artery hardening and cholesterol, blood clotting & inflammation reduction. Consumer demand will be driven by increasing concern about longer life spans and future application reach in the animal nutrition and food & beverage industry.

Market growth is driven by factors such as the growth in demand for fortified foods due to a rising knowledge of health among consumers. Growing incidences of chronic diseases globally and mandates for food fortification by government organisations are key drivers for the growth of the industry. Different producers of nutraceutical ingredients are increasingly embracing personalised healthcare innovations to formulate better-suited and tailored end products for customers. Increasingly, consumer product businesses are now gathering data to allow a proper analysis of buying habits and lifestyle and provide customers with personalised choices in line with their buying trends.

The global nutraceutical ingredients market has been driven by growth in life expectancy & health awareness among customers and increased applications of nutraceutical ingredients. The high costs involved in R&D activities, on the other hand, could impede market growth at a global level.

Report Highlights

  • North America showed prominent growth in the global nutraceutical Ingredients market in 2019 because of growing demand for nutraceutical products.
  • India, which accounted for almost 31.5 percent of the market share in 2019, totally drives the Asia Pacific market for nutraceutical ingredients.
  • As the market for dietary supplements and functional foods in dry form is growing, manufacturing companies are selling products in dry form, either in capsule form or compressed into tablets.
  • Manufacturing companies are selling dry goods in increasing demand for nutritional supplements and functional foods in dry form; these are either available in capsule form or compressed into tablets.

Regional Snapshots

North America is prominent revenue contributor to the global nutraceutical Ingredients industry because of significant demand for healthy food among customers. Owing to rise in anti-aging properties, the rising demand for nutraceutical products has led North America to become a prominent region in the industry. Due to the involvement of major pharmaceuticals and food & beverage producers, the Asia Pacific has seen substantial growth in the past few years. Growing consumer spending on health and wellness goods is likely to be a key factor driving the growth of industry in economies such as the Middle East & Africa and Asia Pacific due to changing lifestyles and increasing disposable income.

Key Players & Strategies

The nutraceutical Ingredients industry is highly opportunistic and competitive in nature because of significant advancements and developments in the product to cater the ever-changing consumer demand. Further, with the changing lifestyle and increasing health issue the demand is changing rapidly that again trigger the rate of competition among the market players. Presently, consumers are more inclined towards healthy products that have forced the manufacturers in the industry to health based products. In the wake of same, the industry players invest prominently in the market to develop new and advanced products.

Some of the key players operating in the market are GlaxoSmithKline, Kraft Heinz Company, Abbott, Kellogg’s, Danone, Cargill Inc., Amway, Nestle, Archer Daniels Midland, DSM, BASF, PepsiCo, General Mills, Aker Biomarine, Procter & Gamble, Johnson & Johnson.

Market Segmentation

By Type

  • Probiotic
  • Proteins and amino acids
  • Phytochemical & plant extracts
  • Fibers & specialty carbohydrates
  • Omega 3 fatty acids
  • Vitamins
  • Prebiotic
  • Carotenoids
  • Minerals
  • Others

By Application

  • Food
  • Beverages
  • Personal care
  • Animal nutrition
  • Dietary supplements

By Health Benefits

  • Cognitive health
  • Gut health
  • Heart health
  • Bone health
  • Immunity
  • Nutrition
  • Weigh management
  • Others

By Form

  • Dry
  • liquid

By Regional

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Rest of the World

Table of Content

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Nutraceutical Ingredients Market, By Product

7.1. Nutraceutical Ingredients Market, by Product Type, 2020-2030
7.1.1. Probiotic
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Proteins and amino acids
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Phytochemical & plant extracts
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Fibers & specialty carbohydrates
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Omega 3 fatty acids
7.1.5.1. Market Revenue and Forecast (2017-2030)
7.1.6. Vitamins
7.1.6.1. Market Revenue and Forecast (2017-2030)
7.1.7. Prebiotic
7.1.7.1. Market Revenue and Forecast (2017-2030)
7.1.8. Carotenoids
7.1.8.1. Market Revenue and Forecast (2017-2030)
7.1.9. Minerals
7.1.9.1. Market Revenue and Forecast (2017-2030)
7.1.10. Others
7.1.10.1. Market Revenue and Forecast (2017-2030)

Chapter 8. Global Nutraceutical Ingredients Market, By Application

8.1. Nutraceutical Ingredients Market, by Application, 2020-2030
8.1.1. Food
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Beverages
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Personal care
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Animal nutrition
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Dietary supplements
8.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Nutraceutical Ingredients Market, By Health Benefits

9.1. Nutraceutical Ingredients Market, by Health Benefits, 2020-2030
9.1.1. Cognitive health
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Gut health
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Heart health
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Bone health
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Immunity
9.1.5.1. Market Revenue and Forecast (2017-2030)
9.1.6. Nutrition
9.1.6.1. Market Revenue and Forecast (2017-2030)
9.1.7. Weigh management
9.1.7.1. Market Revenue and Forecast (2017-2030)
9.1.8. Others
9.1.8.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Nutraceutical Ingredients Market, By Form

10.1. Nutraceutical Ingredients Market, by Form, 2020-2030
10.1.1. Dry
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Liquid
10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Nutraceutical Ingredients Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.1.4. Market Revenue and Forecast, by Form (2017-2030)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.1.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.1.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.1.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.1.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.7.4. Market Revenue and Forecast, by Form (2017-2030)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.2.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.2.8.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.2.8.4. Market Revenue and Forecast, by Form (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.7.4. Market Revenue and Forecast, by Form (2017-2030)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.3.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.3.8.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.3.8.4. Market Revenue and Forecast, by Form (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.6.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.7.4. Market Revenue and Forecast, by Form (2017-2030)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
11.4.8.2. Market Revenue and Forecast, by Application (2017-2030)
11.4.8.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.4.8.4. Market Revenue and Forecast, by Form (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.5.5.4. Market Revenue and Forecast, by Form (2017-2030)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
11.5.6.2. Market Revenue and Forecast, by Application (2017-2030)
11.5.6.3. Market Revenue and Forecast, by Health Benefits (2017-2030)
11.5.6.4. Market Revenue and Forecast, by Form (2017-2030)

Chapter 12. Company Profiles

12.1. Kraft Heinz Company
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. GlaxoSmithKline
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Amway
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Abbott
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Kellogg’s
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Danone
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cargill Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Nestle
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Archer Daniels Midland
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. DSM
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
12.11. BASF
12.11.1. Company Overview
12.11.2. Product Offerings
12.11.3. Financial Performance
12.11.4. Recent Initiatives
12.12. General Mills
12.12.1. Company Overview
12.12.2. Product Offerings
12.12.3. Financial Performance
12.12.4. Recent Initiatives
12.13. Aker Biomarine
12.13.1. Company Overview
12.13.2. Product Offerings
12.13.3. Financial Performance
12.13.4. Recent Initiatives
12.14. Procter & Gamble
12.14.1. Company Overview
12.14.2. Product Offerings
12.14.3. Financial Performance
12.14.4. Recent Initiatives
12.15. Johnson & Johnson
12.15.1. Company Overview
12.15.2. Product Offerings
12.15.3. Financial Performance
12.15.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308


Leave a Reply

Your email address will not be published. Required fields are marked *